Neura unveiled what it says is a “comprehensive solution that enhances mobile apps and devices designed to reduce medication non-adherence,” which happens to be a $300 billion problem in the United States with life-threatening consequences. When integrated with medication management apps and Internet of Things (IoT) devices, Neura’s advanced software as a service (SaaS) will rely on artificial intelligence (AI) to adapt to each user’s needs, helping them change their behavior, follow doctor’s orders more closely, and build healthier habits. In turn, apps using Neura SDK will be able to better understand the user and communicate at moments when he/she is most likely to act. The result is increased adherence and improved general wellness.
Once integrated, Neura’s AI service intuitively learns about a user’s life in the real world and gradually understands the context of such routine activities as waking up, leaving home, dining out, going to the gym, and falling asleep. In time, the software learns to anticipate and adapt to each user’s needs, and translate this awareness into actionable insights. For example, a smart glucometer powered by Neura knows that a particular patient should check her glucose levels before working out, and knows when she arrives at the gym — prompting the glucometer to recommend action precisely at that moment.
“Medication management apps and medical devices enabled by Neura do more for people — they adapt to the user’s day and help the user do what they need to do, right when they need to do it,” Neura co-founder and CEO Gilad Meiri said in a statement. “Users engage with the app more fully, and use it more consistently and frequently, which grows revenues for the app or device provider.”
Neura’s solution includes an add-on library specifically designed to streamline integration with medical and health apps. The add-on delivers pre-built features that are proven to increase user engagement among many of those apps, eliminating the need for app developers to write code for these features, while also enabling them to complete integration in two hours or less.
According to a partnership of physicians and pharmaceutical companies, a 17-percent increase in U.S. emergency room visits and a 10-percent growth in hospital admissions can be attributed to poor medical adherence each year, along with approximately 125,000 deaths.